The global demand for DNA sequencing electrophoresis systems is forecast to grow at a healthy CAGR of around 6% to 6.2% during the forecast period from 2022 to 2032. Growth in the market is driven by rising applications of DNA sequencing electrophoresis systems in fields like microbiology, biochemistry, and pharmaceuticals.
DNA Sequencing Electrophoresis Systems Market Projected Growth Rate (2022-2032) | 6% - 6.2% CAGR |
Advances in medical and biological fields along with complexity associated with various techniques have prompted researchers to employ fast and effective technologies in processes like DNA sequencing. This factor has brought DNA sequencing electrophoresis systems into the limelight.
DNA sequencing electrophoresis systems have become essential equipment for performing electrophoresis, a special technique for separating DNA, RNA and protein based on their size, mass or electrical charge. The technique involves running a current through a gel containing molecules of interest.
Electrophoretic separation of DNA is the most critical step in many genetic analyses. Adoption of DNA sequencing electrophoresis systems increases sequencing and genotyping efficiency and throughput, as well as decreases the overall analysis costs. Advances in microchannel electrophoretic systems for DNA analyses have had important impacts on biomedical and biological sciences and the trend is likely to escalate during the forthcoming period.
The robust expansion of DNA sequencing electrophoresis systems market is attributable to the advancement in biology research and instrumentation fields, rising prevalence of various chronic and infectious diseases, increasing investments in research and development, advancements in medical technologies, and availability of specialized systems for different cell cultures and sample studies.
DNA sequencing electrophoresis systems have become ideal tools used during DNA analysis and medical research activities for separating DNA and protein on the basis of their size and electrical charge. They provide better accuracy, high speed, and precise results, thereby making them ideal for usage in genome analysis.
Increasing investments by companies in chemical and bio-chemical research areas is expected to generate lucrative sales prospects for DNA sequencing electrophoresis systems during the forecast period. DNA sequencing electrophoresis systems are being increasingly used during microbiology and bio-chemical research activities
Similarly, rising adoption of specialised DNA sequencing electrophoresis systems in bio-medical, nanotechnology, and pharmaceutical industries is expected to boost market growth during the forthcoming period.
Additionally, rising government initiatives and funding for research on genomics and proteomics along with advancements in electrophoresis systems will further generate sales prospects for DNA sequencing electrophoresis systems during the assessment period.
Despite its optimistic stance there are several factors that are likely to limit the growth of DNA sequencing electrophoresis systems market during the forecast period. Some of these factors are the delicate nature of CNA sequencing electrophoresis and higher cost of these systems.
In addition to this, reuse of glass-based DNA sequencing electrophoresis systems for a longer period of time is also anticipated to affect the overall demand over the assessment period.
As per FMI, North America currently accounts for the largest market share of the global DNA sequencing electrophoresis systems market and is expected to grow at a robust CAGR over the forecast period between 2022 and 2032. Growth in the market is driven by increasing biological research activities, rising prevalence of chronic disease, growing adoption of DNA sequencing in biological and medical research, and heavy presence of leading manufacturers and suppliers.
The United States remains at the epicenter of DNA sequencing electrophoresis systems market growth, owing to the large presence of clinical, forensics and research laboratories, favorable government support, advancements in medical technologies, and growing adoption of DNA sequencing electrophoresis systems in the field of genomics, proteomics, drug discovery and personalized medicine.
According to Future Market Insights, the Asia Pacific market is expected to witness significant growth during the forecast period, owing to the increasing investments by manufactures in the laboratory instrumentation field, rising penetration of foreign market players, favorable government support, and increase in proteomic and genomics research in countries like China.
Some of the key participants present in the global DNA sequencing electrophoresis systems market include Normax, Thermo Fisher Scientific Inc., Corning Incorporated, BRAND GMBH + CO KG, Deltalab, Paul Marienfeld GmbH & Co. KG, DWK Life Sciences, FL MEDICAL s.r.l., CML Biotech and Boekel Scientific among others.
Most of these players are continuously introducing advanced systems with additional features to increase their sales. Besides this, they are aiming at expanding their presence across emerging economies like Asia Pacific and the Middle East through strategies like new facility establishments, partnerships, acquisitions etc.
Report Attribute | Details |
Growth Rate | CAGR of 6% - 6.2% from 2022 to 2032 |
Base Year for Estimation | 2021 |
Historical Data | 2015-2020 |
Forecast Period | 2022-2032 |
Quantitative Units | Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032 |
Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
Segments Covered |
|
Regions Covered |
|
Key Countries Profiled |
|
Key Companies Profiled |
|
Customization | Available Upon Request |
By Type:
By Application Area:
By Region:
As per FMI, the global DNA sequencing electrophoresis systems market is likely to grow at a CAGR of around 6% to 6.2% CAGR over the forecast period.
North America will continue to remain the most dominant market for DNA sequencing electrophoresis systems during the assessment period.
Normax, Thermo Fisher Scientific Inc., Corning Incorporated, BRAND GMBH + CO KG, and Deltalab are some prominent DNA sequencing electrophoresis systems manufacturers
Explore Similar Insights
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.